Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

被引:67
作者
Mohty, Mohamad [1 ]
Labopin, Myriam [2 ,3 ]
Tabrizzi, Reza [4 ]
Theorin, Niklas [5 ]
Fauser, Axel A. [6 ]
Rambaldi, Alessandro [7 ]
Maertens, Johan [8 ]
Slavin, Shimon [9 ]
Majolino, Ignazio [10 ]
Nagler, Arnon [11 ]
Blaise, Didier [12 ]
Rocha, Vanderson [2 ,3 ,13 ]
机构
[1] Univ Nantes, CHU Hotel Dieu, Serv Hematol Clin, Pl Alexis Ricordeau, F-44093 Nantes, France
[2] Hop St Antoine, AP HP, European Grp Blood & Marrow Transplantat EBMT, Acute Leukemia Working Party, Paris, France
[3] Univ Paris 06, Pierre & Marie Curie, Paris, France
[4] CHU Bordeaux, Hop Haut Leveque, Pessac, France
[5] Univ Hosp, Dept Hematol, Linkoping, Sweden
[6] Klin Knochenmarktransplantat & Haematol Onkol, Idar Oberstein, Germany
[7] Osped Bergamo, Div Ematol, Bergamo, Italy
[8] Univ Hosp Gasthuisberg, Dept Hematol, Leuven, Belgium
[9] Hadassah Univ Hosp, Dept Bone Marrow Transplantat, Jerusalem, Israel
[10] Osped S Camillo Forlanini, Dept Hematol & BMT, Rome, Italy
[11] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Hashomer, Israel
[12] Inst Paoli Calmettes, Unite Transplantat & Therapie Cellulaire, Marseille, France
[13] Hop St Louis, AP HP, Dept Hematol, Paris, France
关键词
allogeneic SCT; acute lymphoblastic leukemia;
D O I
10.3324/haematol.11960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective study reported the outcome of 97 adult acute lymphoblastic leukemia patients who received a reduced-intensity conditioning allogeneic stem cell transplantation. With a median follow-up of 2.8 years, two year overall-survival, leukemia-free survival and non-relapse mortality were significantly better in patients transplanted in first complete remission (CR1, 52 +/- 9%; 42 +/- 10%; and 18 +/- 7% respectively) compared with those transplanted in more advanced phase (p=0.003, p=0.002 and p=0.01 respectively). In multivariate analysis, disease status (CR1 vs. advanced; p=0.001) and chronic graft-vs-host disease (p=0.01) were associated with an improved overall-survival, suggesting that reduced-intensity conditioning allogeneic stem cell transplantation is feasible in patients with high risk lymphoblastic leukemia in remission at transplantation.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 50 条
  • [1] Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia:: a feasibility study
    Martino, R
    Giralt, S
    Caballero, MD
    Mackinnon, S
    Corradini, P
    Fernández-Avilés, F
    San Miguel, J
    Sierra, J
    HAEMATOLOGICA, 2003, 88 (05) : 555 - 560
  • [2] Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients
    T Hamaki
    M Kami
    Y Kanda
    K Yuji
    Y Inamoto
    Y Kishi
    K Nakai
    I Nakayama
    N Murashige
    Y Abe
    Y Ueda
    M Hino
    T Inoue
    H Ago
    M Hidaka
    T Hayashi
    T Yamane
    N Uoshima
    S Miyakoshi
    S Taniguchi
    Bone Marrow Transplantation, 2005, 35 : 549 - 556
  • [3] Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients
    Hamaki, T
    Kami, M
    Kanda, Y
    Yuji, K
    Inamoto, Y
    Kishi, Y
    Nakai, K
    Nakayama, I
    Murashige, N
    Abe, Y
    Ueda, Y
    Hino, M
    Inoue, T
    Ago, H
    Hidaka, M
    Hayashi, T
    Yamane, T
    Uoshima, N
    Miyakoshi, S
    Taniguchi, S
    BONE MARROW TRANSPLANTATION, 2005, 35 (06) : 549 - 556
  • [4] Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
    Stein, Anthony S.
    Palmer, Joycelynne M.
    O'Donnell, Margaret R.
    Kogut, Neil M.
    Spielberger, Ricardo T.
    Slovak, Marilyn L.
    Tsai, Ni-Chun
    Senitzer, David
    Snyder, David S.
    Thomas, Sandra H.
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (11) : 1407 - 1414
  • [5] The role of allogeneic stem cell transplantation for adult acute lymphoblastic leukemia
    Paulson, K.
    Szwajcer, D.
    Seftel, M. D.
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 44 (02) : 197 - 203
  • [6] Role of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia
    Lussana, Federico
    Rambaldi, Alessandro
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
  • [7] Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation
    Secondino, Simona
    Carrabba, Matteo G.
    Pedrazzoli, Paolo
    Castagna, Luca
    Spina, Francesco
    Grosso, Federica
    Bertuzzi, Alexia
    Bay, Jacques-Olivier
    Siena, Salvatore
    Corradini, Paolo
    Niederwieser, Dietger
    Demirer, Taner
    HAEMATOLOGICA, 2007, 92 (03) : 418 - 420
  • [8] Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia
    Marks, David I.
    Alonso, Laura
    Radia, Rohini
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) : 995 - +
  • [9] Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia
    Vaca, Mayra
    Maria Velez, Ana
    Lisa Basquiera, Ana
    Arbelbide, Jorge
    Agustina Perusini, Maria
    Bendek, Georgina
    Berro, Mariano
    Milovic, Vera
    Yantorno, Sebastian
    Cerutti, Amalia
    Cattaneo, Maximiliano
    Bordone, Javier
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S199 - S199
  • [10] Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Nagler, Arnon
    Labopin, Myriam
    Houhou, Mohamed
    Aljurf, Mahmoud
    Mousavi, Ashrafsadat
    Hamladji, Rose-Marie
    Al Zahrani, Mohsen
    Bondarenko, Sergey
    Arat, Mutlu
    Angelucci, Emanuele
    Koc, Yener
    Gulbas, Zafer
    Sica, Simona
    Bourhis, Jean Henri
    Canaani, Jonathan
    Brissot, Eolia
    Giebel, Sebastian
    Mohty, Mohamad
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)